These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12655076)

  • 1. Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the 'loop'.
    Nakagawa N; Kubota R; Nakagawa T; Okuno Y
    J Gen Virol; 2003 Apr; 84(Pt 4):769-773. PubMed ID: 12655076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of new epidemic strains of influenza B virus by using neutralizing monoclonal antibodies.
    Nakagawa N; Kubota R; Morikawa S; Nakagawa T; Baba K; Okuno Y
    J Med Virol; 2001 Dec; 65(4):745-50. PubMed ID: 11745940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains.
    Nakagawa N; Kubota R; Nakagawa T; Okuno Y
    J Gen Virol; 2001 Sep; 82(Pt 9):2169-2172. PubMed ID: 11514726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies to hemagglutinin of influenza b viruses victoria evolutionary lineage.].
    Sorokin EV; Tsareva TR; Zheltukhina AI
    Vopr Virusol; 2018; 63(6):275-280. PubMed ID: 30641023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.
    Brown LE; Murray JM; White DO; Jackson DC
    Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epitope analysis of the hemagglutinin molecule of the Victoria lineage influenza B viruses].
    Sorokin EV; Tsareva TR; Sominina AA; Pisareva MM; Komissarov AV; Kosheleva AA; Grudinin MP
    Vopr Virusol; 2014; 59(6):27-31. PubMed ID: 25929033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.
    Crowther JR; Rowe CA; Butcher R
    Epidemiol Infect; 1993 Oct; 111(2):391-406. PubMed ID: 7691630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing Epitopes and Residues Mediating the Potential Antigenic Drift of the Hemagglutinin-Esterase Protein of Influenza C Virus.
    Matsuzaki Y; Sugawara K; Furuse Y; Shimotai Y; Hongo S; Mizuta K; Nishimura H
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30096880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection and identification of two lineages of influenza B strains with monoclonal antibodies.
    Nakagawa N; Maeda A; Kase T; Kubota R; Okuno Y
    J Virol Methods; 1999 Apr; 79(1):113-20. PubMed ID: 10328540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of an influenza B virus with antigenic change.
    Nakagawa N; Nukuzuma S; Haratome S; Go S; Nakagawa T; Hayashi K
    J Clin Microbiol; 2002 Aug; 40(8):3068-70. PubMed ID: 12149383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.
    Nakagawa N; Suzuoki J; Kubota R; Kobatake S; Okuno Y
    J Clin Microbiol; 2006 Apr; 44(4):1564-6. PubMed ID: 16597895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.
    Vigil A; Estélles A; Kauvar LM; Johnson SK; Tripp RA; Wittekind M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences.
    Nakagawa N; Kubota R; Maeda A; Nakagawa T; Okuno Y
    J Clin Microbiol; 2000 Sep; 38(9):3467-9. PubMed ID: 10970406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.
    Coelingh KV; Winter CC
    J Virol; 1990 Mar; 64(3):1329-34. PubMed ID: 1689394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.
    Glaser AL; de Vries AA; Dubovi EJ
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2223-33. PubMed ID: 7561759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan.
    Nakagawa N; Kubota R; Okuno Y
    J Clin Microbiol; 2005 Aug; 43(8):4212-4. PubMed ID: 16081981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains.
    Doyle TM; Li C; Bucher DJ; Hashem AM; Van Domselaar G; Wang J; Farnsworth A; She YM; Cyr T; He R; Brown EG; Hurt AC; Li X
    Biochem Biophys Res Commun; 2013 Nov; 441(1):226-9. PubMed ID: 24140051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.
    Fallahi F; Wandeler AI; Nadin-Davis SA
    Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.